Periscope Capital’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,278,785
Closed -$12.7M 1004
2022
Q3
$12.7M Sell
1,278,785
-353,353
-22% -$3.5M 0.37% 36
2022
Q2
$16.1M Buy
1,632,138
+7,938
+0.5% +$78K 0.43% 15
2022
Q1
$15.9M Buy
1,624,200
+273,518
+20% +$2.67M 0.41% 16
2021
Q4
$13.2M Sell
1,350,682
-600
-0% -$5.86K 0.35% 42
2021
Q3
$13.2M Buy
1,351,282
+79,800
+6% +$772K 0.39% 34
2021
Q2
$12.3M Buy
1,271,482
+60,894
+5% +$591K 0.4% 39
2021
Q1
$11.7M Buy
+1,210,588
New +$12.1M 0.46% 34

Periscope Capital's HCAR Position: Q4 2022 in Review

Periscope Capital sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 1,278,785 shares — an estimated $12.7M sold.

Periscope Capital first reported a position in HCAR in Q1 2021 and held it in 7 quarters. The position peaked at $16.1M in Q2 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

  • Periscope Capital reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Periscope Capital sold 1,278,785 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $12.7M.
  • Periscope Capital first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Periscope Capital's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $16.1M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Periscope Capital's 13F filing for Q4 2022, filed 13 Feb 2023.